05 Feb 2025
// PR NEWSWIRE
24 Jan 2025
// PR NEWSWIRE
18 Nov 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
Reset all filters
01 3ASENAPINE MALEATE
02 2ASPIRIN; BUTALBITAL; CAFFEINE
03 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
04 2BRIMONIDINE TARTRATE
05 2CHLORAMPHENICOL
06 1CHLORAMPHENICOL; PREDNISOLONE
07 1CROMOLYN SODIUM
08 1CYCLOSPORINE
09 1DEXAMETHASONE
10 2DICYCLOMINE HYDROCHLORIDE
11 3DILTIAZEM HYDROCHLORIDE
12 1DIPIVEFRIN HYDROCHLORIDE
13 1EPINASTINE HYDROCHLORIDE
14 1ESTRADIOL
15 4ETHINYL ESTRADIOL; NORETHINDRONE
16 1ETHOXZOLAMIDE
17 1FERRIC OXYHYDROXIDE
18 4FLUOCINOLONE ACETONIDE
19 1FLUOROMETHOLONE
20 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
21 1FLURBIPROFEN SODIUM
22 1GATIFLOXACIN
23 1GENTAMICIN SULFATE
24 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
25 5HYDROCORTISONE
26 2HYDROXYPROGESTERONE CAPROATE
27 1IDOXURIDINE
28 1KETOROLAC TROMETHAMINE
29 2LEVOBUNOLOL HYDROCHLORIDE
30 6LIOTRIX (T4;T3)
31 1MEDRYSONE
32 1MEMANTINE HYDROCHLORIDE
33 12MORPHINE SULFATE
34 1NAPHAZOLINE HYDROCHLORIDE
35 4NEBIVOLOL HYDROCHLORIDE
36 1NEDOCROMIL SODIUM
37 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
38 1OFLOXACIN
39 2OXYBUTYNIN
40 5OnabotulinumtoxinA
41 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
42 1PODOFILOX
43 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
44 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
45 1PROPARACAINE HYDROCHLORIDE
46 1SELENIUM SULFIDE
47 3SULFACETAMIDE SODIUM
48 5TAZAROTENE
49 2TRETINOIN
50 1TRIAMCINOLONE ACETONIDE
51 3TRIMEPRAZINE TARTRATE
52 2TROSPIUM CHLORIDE
53 2URSODIOL
Reset all filters
01 2AEROSOL;TOPICAL
02 17CAPSULE, EXTENDED RELEASE;ORAL
03 3CAPSULE;ORAL
04 7CREAM;TOPICAL
05 1CREAM;VAGINAL
06 1EMULSION; OPHTHALMIC
07 1FILM, EXTENDED RELEASE;TRANSDERMAL
08 1GEL, METERED;TRANSDERMAL
09 5GEL;TOPICAL
10 3INJECTABLE;INJECTION
11 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
12 1LOTION/SHAMPOO;TOPICAL
13 6OINTMENT;OPHTHALMIC
14 2OINTMENT;TOPICAL
15 21SOLUTION/DROPS;OPHTHALMIC
16 1SOLUTION;ORAL
17 2SOLUTION;TOPICAL
18 3SUSPENSION/DROPS;OPHTHALMIC
19 2SUSPENSION;OPHTHALMIC
20 1SYRUP;ORAL
21 17TABLET;ORAL
22 2TABLET;ORAL-21
23 2TABLET;ORAL-28
24 3TABLET;SUBLINGUAL
25 5VIAL; SINGLE-USE
Reset all filters
01 20.01%
02 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
03 10.0125MG;0.0031MG
04 30.025%
05 10.025MG;0.0063MG
06 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 20.035MG;0.5MG
08 20.035MG;1MG
09 10.0375%
10 30.05%
11 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
12 10.05MG;0.0125MG
13 10.075%
14 60.1%
15 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
16 10.1%;10%
17 10.12%;0.1%
18 10.15MG;0.0375MG
19 10.1MG;0.025MG
20 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
21 20.2%;10%
22 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 10.25MG;0.0625MG
24 20.3%
25 60.5%
26 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 51%
28 11%;0.5%
29 210%
30 110,000 UNITS/ML;EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
31 2100 UNITS/VIAL
32 1100MG
33 110MG
34 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 1125MG
37 1125MG/ML
38 1130MG
39 1150MG
40 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
41 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
42 22.5%
43 1200 UNITS/VIAL
44 1200MG
45 120MG
46 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
47 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
48 1250MG
49 1250MG/ML
50 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 13%
52 13.9MG/24HR
53 130%
54 130MG
55 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
56 1325MG;50MG;40MG;30MG
57 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
58 140MG
59 250 UNITS/VIAL
60 1500MG
61 150MG
62 160MG
63 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
64 170MG
65 180MG
66 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
67 1EQ 0.3% BASE
68 1EQ 0.3% BASE;0.6%
69 1EQ 0.3% BASE;1%
70 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
71 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
72 2EQ 10MG BASE
73 3EQ 2.5MG BASE
74 1EQ 2.5MG BASE/5ML
75 1EQ 20MG BASE
76 3EQ 5MG BASE
Reset all filters
01 84DISCN
02 20RX
03 6Blank
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2015-03-12
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 1990-10-26
Application Number : 19429
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.5%
Approval Date : 1997-03-13
Application Number : 20490
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.2% **Federal Register ...
Approval Date : 1996-09-06
Application Number : 20613
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : CHLOROPTIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 50091
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : OINTMENT; OPHTHALMIC
Proprietary Name : CHLOROPTIC S.O.P.
Dosage Strength : 1%
Approval Date : 1982-01-01
Application Number : 61187
RX/OTC/DISCN : DISCN
RLD : No
TE Code :